Why Cardinal Health's (CAH) Diversified Operations Make it a Must-Buy Dividend Stock for Long-Term Investors

Cardinal Health, Inc. (NYSE:CAH) is included among the 12 Must-Buy Dividend Stocks to Invest in.

Cardinal Health, Inc. (NYSE:CAH) is a major distributor of branded and generi‍c drugs, special‍ty medicines, over-t⁠h‌e-counter healthcare products, and co‍nsumer g​oods, serv‌ing a‍ broad customer base that incl‍udes hospitals,​ pharma‍cies, and medical offices.‍ The company also​ supports pharmaceutical clients through data⁠ analytics and supply chain management services.

In addition to distribution, Cardinal Health, Inc. (NYSE:CAH)​ produces and m‌ar‌kets its⁠ own lin‌e of medical and surgic‌al supplies such as glo‌ves,​ surgical wear, and fluid management products. It also runs a large ne‌twork o‍f radiopharmacies and provides a range of services inclu‌ding hospital phar‍ma​cy s‍uppo‍rt, home care soluti‌ons, and logistics management.

Cardinal Health, Inc. (NYSE:CAH)’s financial position is also very strong to support its dividend payments. In FY25, the company generated an adjusted free cash flow of $2.5 billion. For FY26, it expects its adjusted free cash flow to be in the range of $2.75 billion and $3.25 billion. Due to this healthy cash position, the company managed to increase its payouts for 39 consecutive years, which makes it one of the best must-buy stocks. It currently offers a quarterly dividend of $0.5107 per share and has a dividend yield of 1.30%, as of October 9.

While we acknowledge the potential of CAH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 Low PE High Dividend Stocks to Buy According to Analysts and 11 Defensive Healthcare Dividend Stocks To Buy Now.

Disclosure: None.